{{ $ActivityName }}
BCLC A
BCLC B
BCLC C
BCLC D
Viral ( Hepatitis or any other)
Non-viral (NASH/NAFLD)
Child Pugh A
Child Pugh B
Child Pugh C
<400ng/ml
>400ng/ml
0
1
2
3
4
4mg OD
8mg OD
12mg OD
Any other
Newly diagnosed HCC
Relapsed HCC
Locoregional therapy [TACE/TARE]
Sorafenib
Atezolizumab + Bevacizumab
Complete response
Partial response
Stable response
Not evaluated
Cash
Govt. Reimbursed
Insurance
State Yojana/ Ayushman Bharat Scheme
2-4 months
4-6 months
>6 months